Syngene International gains on inking pact with Deerfield Discovery and Development Corporation

20 Nov 2020 Evaluate

Syngene International is currently trading at Rs. 572.10, up by 4.70 points or 0.83% from its previous closing of Rs. 567.40 on the BSE.

The scrip opened at Rs. 572.10 and has touched a high and low of Rs. 575.15 and Rs. 567.40 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 596.85 on 24-Sep-2020 and a 52 week low of Rs. 201.65 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 582.15 and Rs. 561.00 respectively. The current market cap of the company is Rs. 22696.00 crore.

The promoters holding in the company stood at 70.61%, while Institutions and Non-Institutions held 21.26% and 8.13% respectively.

Syngene International and Deerfield Discovery and Development Corporation (3DC), the drug discovery and development subsidiary of Deerfield Management Company (Deerfield), have signed an agreement to collaborate to advance therapeutic discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation.

This five-year collaboration unites the core skills of the investment management company Deerfield, through its drug discovery and development arm 3DC, and Syngene’s integrated drug discovery (IDD) services.

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.

Syngene Internation. Share Price

869.40 21.85 (2.58%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 869.40
Sagility India 28.03
AGS Transact Tech 79.99
Just Dial 1073.50
Krystal Integrated 643.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.